161 related articles for article (PubMed ID: 3008399)
1. Indolent nonseminomatous germ cell tumor of testis. Prolonged survival of patient with persistent metastatic disease.
Baker TM; Chan AH; Stutz FH
Urology; 1986 Apr; 27(4):349-52. PubMed ID: 3008399
[TBL] [Abstract][Full Text] [Related]
2. Surgical Management of Cervical Non-seminomatous Germ Cell Tumor Metastases.
Nwosu OI; Jones AJ; Alwani M; Einhorn LH; Moore MG; Mantravadi AV
Laryngoscope; 2021 Jul; 131(7):1528-1534. PubMed ID: 33421136
[TBL] [Abstract][Full Text] [Related]
3. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
[TBL] [Abstract][Full Text] [Related]
4. [Clinical evaluation of nonseminomatous testicular germ cell tumors].
Nukui M; Nakao M; Nakagawa S; Takada H; Ebisui K; Sugimoto K; Watanabe H; Maekawa M
Hinyokika Kiyo; 1991 Oct; 37(10):1281-5. PubMed ID: 1721771
[TBL] [Abstract][Full Text] [Related]
5. Testicular germ cell tumors in boys <10 years: results of the protocol MAHO 98 in respect to surgery and watch & wait strategy.
Göbel U; Haas R; Calaminus G; Botorek P; Schmidt P; Teske C; Schönberger S; Schneider DT; Harms D
Klin Padiatr; 2013 Nov; 225(6):296-302. PubMed ID: 24158884
[TBL] [Abstract][Full Text] [Related]
6. Assessing prognosis and optimizing treatment in patients with postchemotherapy viable nonseminomatous germ-cell tumors (NSGCT): results of the sCR2 international study.
Fizazi K; Oldenburg J; Dunant A; Chen I; Salvioni R; Hartmann JT; De Santis M; Daugaard G; Flechon A; de Giorgi U; Tjulandin S; Schmoll HJ; Bouzy J; Fossa SD; Fromont G
Ann Oncol; 2008 Feb; 19(2):259-64. PubMed ID: 18042838
[TBL] [Abstract][Full Text] [Related]
7. Survival after an antiangiogenetic therapy and surgery in a wide spread growing teratoma originating from a testicular mixed malignant germ cell tumor.
Calaminus G; Schneider DT; Weissbach L; Schönberger S; Okpanyi V; Leuschner I; Poremba C; Göbel U
Klin Padiatr; 2009; 221(3):136-40. PubMed ID: 19437360
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour.
Shayegan B; Carver BS; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
BJU Int; 2007 May; 99(5):993-7. PubMed ID: 17437432
[TBL] [Abstract][Full Text] [Related]
9. Patients with non-seminoma germ cell tumours treated in a minor oncology department: the importance of multi-institutional protocols and research collaboration.
Kildahl-Andersen A; Erke MG; Sagstuen H; Bremnes RM
Acta Oncol; 2005; 44(6):537-44. PubMed ID: 16165912
[TBL] [Abstract][Full Text] [Related]
10. Predictors of outcome in patients with advanced nonseminomatous germ cell testicular tumors.
Yetisyigit T; Babacan N; Urun Y; Seber ES; Cihan S; Arpaci E; Yildirim N; Aksoy S; Budakoglu B; Zengin N; Oksuzoglu B; Yalcin BC; Alkis N
Asian Pac J Cancer Prev; 2014; 15(2):831-5. PubMed ID: 24568504
[TBL] [Abstract][Full Text] [Related]
11. A third option in the management of patients with clinical stage I nonseminomatous germ cell tumor?
Gressler VH; Levine LA; Vogelzang NJ
J Clin Oncol; 1990 Jan; 8(1):4-8. PubMed ID: 2153195
[No Abstract] [Full Text] [Related]
12. Surveillance alone in the treatment of clinical stage I nonseminomatous germ cell tumor of the testis (NSGCT).
Sogani PC; Fair WR
Semin Urol; 1988 Feb; 6(1):53-6. PubMed ID: 2838876
[No Abstract] [Full Text] [Related]
13. ["Growing teratoma syndrome": an unrecognized complication of treated germ cell tumors of the testis].
Ghaouti M; Roquet L; Fazzalari L; Sibert L; Sabourin JC
Ann Pathol; 2013 Dec; 33(6):402-5. PubMed ID: 24331722
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of patients with retroperitoneal metastases of nonseminoma tumors of the testis].
Matveev BP; Figurin KM
Vopr Onkol; 1988; 34(12):1493-7. PubMed ID: 2464238
[TBL] [Abstract][Full Text] [Related]
15. Contemporary management of postchemotherapy testis cancer.
Daneshmand S; Albers P; Fosså SD; Heidenreich A; Kollmannsberger C; Krege S; Nichols C; Oldenburg J; Wood L
Eur Urol; 2012 Nov; 62(5):867-76. PubMed ID: 22938868
[TBL] [Abstract][Full Text] [Related]
16. The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumor.
Dash A; Carver BS; Stasi J; Bajorin DF; Motzer RJ; Bosl GJ; Sheinfeld J
Cancer; 2008 Feb; 112(4):800-5. PubMed ID: 18172902
[TBL] [Abstract][Full Text] [Related]
17. Orchiectomy only for clinical stage I nonseminomatous germ cell testis tumors: comparison with pathologic stage I disease.
Freiha F; Torti F
Urology; 1989 Dec; 34(6):347-8. PubMed ID: 2556828
[TBL] [Abstract][Full Text] [Related]
18. [Testicular tumors. Mortality and recurrence after inadequate therapy].
Albers P; Dommer K; Müller SC
Urologe A; 1998 Nov; 37(6):625-8. PubMed ID: 9887491
[TBL] [Abstract][Full Text] [Related]
19. A case of spermatic cord teratoma in low-stage testicular cancer managed by surveillance.
Subramanian VS; Gilligan T; Klein EA
Nat Clin Pract Urol; 2008 Apr; 5(4):220-3. PubMed ID: 18268549
[TBL] [Abstract][Full Text] [Related]
20. Late recurrence of testicular cancer.
Embil JM; Weinerman BH; Pascoe EA
Can J Surg; 1994 Apr; 37(2):165-7. PubMed ID: 8156473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
